Lisata Therapeutics, Inc. (LSTA)

NASDAQ

$1.12

$+0.06

(+5.26%)

Pre-Market

Lisata Therapeutics, Inc. (LSTA) Live Price Chart

Last updated: ⁦2026-10-14 09:51:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Lisata Therapeutics, Inc. (LSTA) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1.12, with a market capitalisation of $11.34M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.98 to $5.07. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$11.34M
Open	$1.07
Day's High	$9.38
Day's Low	$0.98
Previous Close	$1.08
Volume	20.00
Average Volume	312.06K
P/E Ratio	--
52-Week High	$5.07
52-Week Low	$0.98
Dividend Yield	--
Earnings Date	--

Lisata Therapeutics, Inc. (LSTA) Pre-Market Stock Price

Lisata Therapeutics, Inc. (LSTA) is trading at $1.12 in pre-market trading as of 2026-10-14 08:35:00, up 3.80% ($0.04) from the previous close of $1.08

Pre-market trading shows how investors are pricing LSTA before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Lisata Therapeutics, Inc. (LSTA) 7-Day Stock Price Change

Over the past seven days, Lisata Therapeutics, Inc. (LSTA) moved from $1.26 to $1.12, representing a decline of 11.03% ($0.14).

The stock traded between $0.98 and $1.48 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 218.16 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

LSTA 52-Week Price Position

Position in Range: 3.4%

52W Low$0.98

52W High$5.07

LSTA is currently trading at $1.12, placing it 3.4% of the way from its 52-week low of $0.98 to its 52-week high of $5.07. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Lisata Therapeutics, Inc. (LSTA)?

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.

Lisata Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	21
Exchange	NASDAQ
Company Website	https://www.lisata.com

How to Buy Lisata Therapeutics, Inc. (LSTA) Stock on MEXC

Eligible investors can buy real shares of Lisata Therapeutics, Inc. (LSTA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for LSTA and Place Your Order

Open the RealStocks trading page and search for LSTA. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Lisata Therapeutics, Inc. (LSTA) stock price today?

Lisata Therapeutics, Inc. (LSTA) is currently trading at $ 1.12, up 3.80% ($0.04) from the previous close of $ 1.08. Intraday prices update in real time during regular trading hours.

2.Is LSTA stock going up or down today?

As of 2026-10-14 08:35:00, LSTA is trading at $ 1.12, up 3.80% ($0.04) from its previous close of $ 1.08. The stock has traded between $ 0.98 and $ 9.38 during today’s regular session. Past price movements do not guarantee future results.

3.What is LSTA pre-market price?

As of 2026-10-14 08:35:00, LSTA is trading at $ 1.12 in pre-market trading, up 3.80% ($0.04) from the previous close of $ 1.08. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is LSTA after-hours price?

As of 2026-10-14 08:35:00, LSTA is trading at $ 1.07 in after-hours trading, down 1.30% ($0.01) from the regular-session close of $ 1.08. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is LSTA stock trading now?

LSTA trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does LSTA sit relative to its 52-week high and low?

Over the past 52 weeks, LSTA has traded between a low of $ 0.98 and a high of $ 5.07. At $ 1.12, the stock is positioned 3.4% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Lisata Therapeutics, Inc. in?

Lisata Therapeutics, Inc. (LSTA) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Lisata Therapeutics, Inc.'s market capitalisation and where is it listed?

Lisata Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 11.34M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is LSTA valued in terms of P/E ratio and EPS?

LSTA trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1.35. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Lisata Therapeutics, Inc. pay a dividend?

Lisata Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.